Skip to main content
. 2024 May 15;59(2):138–146. doi: 10.1097/MCG.0000000000002006

FIGURE 1.

FIGURE 1

Treatment satisfaction among adolescents (caregiver-reported) and adults (self-reported) with EoE who were receiving off-label corticosteroids overall (A) and among those who were taking a budesonide slurry or using a fluticasone oral inhaler (B), across 3 domains of satisfaction assessed using the TSQM-9. Corticosteroid treatment satisfaction was assessed using the TSQM-9 (version 1.4); scores range from 0 to 100 for each domain, with higher scores indicating greater satisfaction. EoE indicates eosinophilic esophagitis; TSQM-9, 9-item Treatment Satisfaction Questionnaire for Medication.